Search results for "Implantable"

showing 10 items of 60 documents

Evidence-Based Strategies to Promote Long-Term Cardiac Implant Site Health: Review of the Literature

2021

Cardiac implantable electronic devices (CIEDs) are commonly used nowadays. The association between CIED placement and infections is responsible for the high mortality and device explantation rate. Since CIED placement has increased in the past decade, CIED-related complications have risen. In order to reduce the CIED-related complications rate, the prevention of device infection represents the main goal. Over time, many different studies have proven the importance of the measures to prevent CIED-related infections. This review aims to collect the actual recommendations for CIED infection prevention, providing an overview of the main evidence-based strategies.

medicine.medical_specialtyEvidence-based practicebusiness.industrymicrobiologyHigh mortalityCardiologyGeneral EngineeringHealthcare Technologycardiac implantable electronic device (cied)030204 cardiovascular system & hematologyinfectionsurgery03 medical and health sciences0302 clinical medicinepreventionCardiac/Thoracic/Vascular SurgerymedicineInfection controlIntensive care medicinebusinessCardiac implant030217 neurology & neurosurgeryCureus
researchProduct

Migraine and cluster headache – the common link

2018

Abstract Although clinically distinguishable, migraine and cluster headache share prominent features such as unilateral pain, common pharmacological triggers such glyceryl trinitrate, histamine, calcitonin gene-related peptide (CGRP) and response to triptans and neuromodulation. Recent data also suggest efficacy of anti CGRP monoclonal antibodies in both migraine and cluster headache. While exact mechanisms behind both disorders remain to be fully understood, the trigeminovascular system represents one possible common pathophysiological pathway and network of both disorders. Here, we review past and current literature shedding light on similarities and differences in phenotype, heritability…

medicine.medical_specialtyNeurologyCluster headacheImplantable Neurostimulators/statistics & numerical dataPain medicineCalcitonin Gene-Related PeptideDeep Brain StimulationMigraine DisordersNitroglycerin/adverse effectsHypothalamuslcsh:MedicineTriptansReviewCalcitonin gene-related peptideBioinformatics03 medical and health sciencesNitroglycerin0302 clinical medicinemedicineHumans030212 general & internal medicineTryptamines/pharmacologyMigraineTrigeminovascular systembusiness.industryNeuromodulationCluster Headache/bloodCluster headacheAnti-CGRP (receptor) monoclonal antibodies – mAbsMigraine Disorders/bloodTrigeminovascular systemlcsh:RGeneral MedicineCalcitonin gene-related peptide (CGRP)medicine.diseaseDeep Brain Stimulation/statistics & numerical dataNeuromodulation (medicine)Tryptamines3. Good healthCalcitonin Gene-Related Peptide/antagonists & inhibitorsAnesthesiology and Pain MedicineImplantable NeurostimulatorsMigraineNeurology (clinical)business030217 neurology & neurosurgerymedicine.drugThe Journal of Headache and Pain
researchProduct

Focus on right ventricular outflow tract septal pacing

2013

SummaryExperimental and clinical studies have shown that right ventricular apical pacing may result in long-term deleterious effects on account of its negative impact on left ventricular remodeling through desynchronization. This risk appears more pronounced in patients with even moderate left ventricular dysfunction and generally occurs after at least 1 year of pacing. As right ventricular apical pacing may be associated with the development of organic mitral insufficiency, other sites that allow for more physiological stimulation, such as right ventricular outflow tract septal pacing, have been developed, with good feasibility and reproducibility. However, the prospective randomized studi…

medicine.medical_specialtyPacemaker Artificialmedicine.medical_treatmentHeart VentriclesCardiac resynchronization therapyStimulation infundibulaireElectric CountershockVentricular SeptumMedium termCardiac Resynchronization TherapyDefibrillatorVentricular Dysfunction LeftInternal medicineMedicineVentricular outflow tractHumanscardiovascular diseasesDéfibrillateurCardiac Resynchronization Therapy DevicesVentricular remodelingHeart FailureStimulation septaleStimulation apicaleEjection fractionbusiness.industryHazard ratioCardiac Pacing ArtificialAtrial fibrillationStroke VolumeGeneral MedicineEquipment Designmedicine.diseaseDefibrillators ImplantablePacemakerTreatment OutcomeHomogeneousInfundibular pacingAnesthesiaCardiologycardiovascular systemVentricular Function RightSeptal pacingApical pacingbusinessCardiology and Cardiovascular MedicineArchives of Cardiovascular Diseases
researchProduct

Use of wearable cardioverter‐defibrillator in association with catheter ablation for atrial fibrillation‐related tachycardiomyopathy

2019

Implantable cardioverter‐defibrillator (ICD) implantation is not indicated in patients with potentially transient or reversible causes of sudden cardiac death (SCD). Wearable cardioverter‐defibrillator (WCD) is increasingly used for SCD prevention in patients who are temporary at high risk of ventricular arrhythmia. Hereby, we describe a case of tachycardiomyopathy successfully managed with ablation and WCD backup. Implantable cardioverter‐defibrillators are a Class I indication by American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines to prevent SCD in patients with nonischemic dilated cardiomyopathy, New York Heart Association (NYHA) functional class II …

medicine.medical_specialtycongenital hereditary and neonatal diseases and abnormalitiesimplantable cardioverter defibrillatormedicine.medical_treatmentCatheter ablationCase ReportCase Reports030204 cardiovascular system & hematologySudden cardiac death03 medical and health sciences0302 clinical medicineInternal medicinehemic and lymphatic diseasescatheter ablationmedicineatrial fibrillationcardiovascular diseasesEjection fractionwearable cardioverter defibrillatorbusiness.industryDilated cardiomyopathyAtrial fibrillationGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillator030220 oncology & carcinogenesisHeart failureCardiologycardiovascular systembusinessWearable cardioverter defibrillatorClinical Case Reports
researchProduct

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis

2021

Abstract Aims Cardiac resynchronization therapy (CRT) is highly effective in dilated cardiomyopathy (DCM) patients with impaired left ventricular ejection fraction (LVEF) and left bundle block branch. In cardiac amyloidosis (CA) patients, left ventricular dysfunction and conduction defects are common, but the potential of CRT to improve cardiac remodelling and survival in this particular setting remains undefined. We investigated cardiovascular outcomes in CA patients after CRT implantation in terms of CRT echocardiographic response and major cardiovascular events (MACEs). Methods and results Our retrospective study included 47 CA patients implanted with CRT devices from January 2012 to Feb…

medicine.medical_specialtygenetic structuresmedicine.medical_treatmentPopulationCardiac resynchronization therapyHeart failureCardiac amyloidosisVentricular Function LeftInternal medicineImplantable cardioverter defibrillatormedicineHumansDiseases of the circulatory (Cardiovascular) systemcardiovascular diseaseseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studyCardiac resynchronization therapyEjection fractionbusiness.industryHazard ratioDilated cardiomyopathyStroke VolumeOriginal ArticlesAmyloidosismedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantablePacemakerTreatment OutcomeCardiac amyloidosisHeart failureRC666-701Cardiologycardiovascular systemOriginal ArticleCardiology and Cardiovascular Medicinebusinesstherapeuticscirculatory and respiratory physiologyESC Heart Failure
researchProduct

Update on Brugada Syndrome 2019

2021

Brugada syndrome (BrS) was first described in 1992 as an aberrant pattern of ST segment elevation in right precordial leads with a high incidence of sudden cardiac death (SCD) in patients with structurally normal heart. It represents 4% ∼ 12% of all SCD and 20% of SCD in patients with structurally normal heart. The extremely wide genetic heterogeneity of BrS and other inherited cardiac disorders makes this new area of genetic arrhytmology a fascinating one. This review shows the state of art in diagnosis, management, and treatment of BrS focusing all the aspects regarding genetics and Preimplant Genetic Diagnosis (PGD) of embryos, overlapping syndromes, risk stratification, familial screeni…

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyRisk Assessmentsudden cardiac deathSudden cardiac deathElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansST segmentBrugada syndromeIn patient030212 general & internal medicineCardiac disordersBrugada syndromeMedicine(all)business.industryGenetic heterogeneityGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorBrugada Syndrome.Defibrillators ImplantableCardiologyhigh incidenceCardiology and Cardiovascular MedicinebusinessRisk assessmentCurrent Problems in Cardiology
researchProduct

Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Cas…

2020

Abstract Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.

medicine.medical_specialtymedicine.medical_treatmentARNIlcsh:Medicineheart failureCase ReportheartCase Reports030204 cardiovascular system & hematologySacubitril03 medical and health sciences0302 clinical medicineInternal medicinemedicineEnalaprilVentricular remodelingReverse remodelingarrhythmic burdenremodelinglcsh:R5-920business.industrylcsh:RGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorfailureValsartan030220 oncology & carcinogenesisHeart failureCardiologylcsh:Medicine (General)businessSacubitril Valsartanmedicine.drugClinical Case Reports
researchProduct

Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art

2014

No abstract available

medicine.medical_specialtymedicine.medical_treatmentDecision MakingCardiomyopathySudden deathImplantable cardioverter-defibrillatorAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden death; Arrhythmogenic Right Ventricular Dysplasia; Decision Making; HumansAntiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter-defibrillator; Management; Radiofrequency catheter ablation; Sudden deathInternal medicinemedicineHumansIn patientIntensive care medicineArrhythmogenic Right Ventricular DysplasiaRadiofrequency catheter ablationbusiness.industrySudden deathImplantable cardioverter-defibrillatormedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareArrhythmogenic right ventricular dysplasiaAntiarrhythmic drugsManagementAntiarrhythmic drugRadiofrequency catheter ablationCardiologyCardiac transplantationTreatment decision makingCardiology and Cardiovascular Medicinebusiness
researchProduct

Continuous subcutaneous Insulin infusion leads to immediate, table, and long-term changes in metabolic control

2008

Background:  Evaluations of continuous subcutaneous insulin infusion (CSII) usually focus on one pre- and one post-CSII measurement to assess metabolic therapy outcome. Aim:  Extending this research, the aim of the present study was to provide a more fine-grained analysis of achieved glycaemic control. Methods:  In 52 patients with type 1 diabetes (mean age of 37.85 years at CSII begin; s.d. ± 12.41), haemoglobin A1c (HbA1c) levels were assessed every 3 months over a period of 5 years (1 year before and 4 years after the introduction of CSII). Mixed models were utilized to describe changes in glycaemic control. Results:  The pre–post course showed that already in the first quarter, a statis…

mixed modelsAdultBlood GlucoseMalemedicine.medical_specialtyPediatricstype 1 diabetesEndocrinology Diabetes and MetabolismModels BiologicalDrug Administration ScheduleTimeHba1c levelEndocrinologyDiabetes mellitusInternal Medicinemedicinefollow upHumansHypoglycemic AgentsInsulinAge of OnsetGlycated HemoglobinType 1 diabetesHaemoglobin A1cbusiness.industry10093 Institute of PsychologyCSIIMean ageInfusion Pumps ImplantableMiddle AgedPrognosismedicine.diseaseSubcutaneous insulinSurgery1310 Endocrinologylong-term changes2712 Endocrinology Diabetes and MetabolismDiabetes Mellitus Type 1Treatment Outcome2724 Internal MedicineMetabolic control analysisFemalebusiness150 PsychologyFollow-Up StudiesMetabolic therapy
researchProduct

Optical quality of hyperopic and myopic phakic intraocular lenses

2013

Aims: To assess and compare the optical quality of the myopic and hyperopic implantable collamer lens (ICL) from its wavefront aberrations for different powers and pupil diameters. Settings and Design: Prospective study. Material and Methods: The wavefront aberrations of two myopic (−3 and −6 diopters (D)) and two hyperopic V4b ICLs (+3 and +6D) were measured in vitro . To assess and compare the optical quality of different powers of ICLs, we analyzed the root mean square (RMS) of total higher order aberrations (HOAs), trefoil, coma, tetrafoil, secondary astigmatism, and spherical aberration at 3- and 4.5-mm pupil. In addition, the point spread functions (PSFs) of each ICL evaluated were ca…

steep corneal curvatureintravitreallacrimal fossaRefractive errorvisual acuitygenetic structurespterygium surgerystandard automated perimetryComa (optics)BlindnessPhakic intraocular lenslaw.inventionsubconjunctival bevacizumab injectionCorneaLens Implantation Intraocularlcsh:Ophthalmologylawmodified deep anterior lamellar keratoplastyMitomycin CMaterials TestingAutogenous tissue graftingProspective StudiesDioptreoptical qualityshort wave automated perimetryexcimer lasernon-proliferative diabetic retinopathyMean deviationin vitroheavy silicone oilBevacizumabLens (optics)Aberrations of the eyeSpherical aberrationHyperopiaAntimicrobial effectOriginal ArticleTriamcinolone acetonidehuman trabecular meshwork cellsPhakic Intraocular Lensesmedicine.medical_specialtyImaging in glaucomadisability evaluationconventional silicone oiltriamcinoloneProsthesis DesignKeratoconusphotorefractive keratectomyOphthalmologygrowth factorsmedicineHumansmyopiamyopic implantable collamer lensshort fluctuationsWavefrontmacular edemaoptical coherence tomographyendophthalmitis agentsbusiness.industrybranch retinal vein occlusionretinal nerve fiber layerpterygium recurrencemedicine.diseaseeye diseasesOphthalmologypediatricwavefront aberrationsquality of lifelcsh:RE1-994bypass surgeryHyperopic implantable collamer lenslacrimal drainage systemsense organsbusinessIndian Journal of Ophthalmology
researchProduct